Q Fever News and Research

RSS

New $29 million grant awarded to five leading children’s hospitals for improving pandemic readiness

A group of children's hospitals from across the country will coordinate on the response to future pandemics and other disasters through a new $29 million grant from the Health Resources and Services Administration (HRSA).

19 Jul 2022

CDC experts update on monkeypox in the United States

Scientists working with the CDC provide the latest information about monkeypox in the U.S.

19 Jul 2022

Study shows how a critical Lassa virus protein drives infection

Lassa fever is a viral illness that is far too common in West Africa. Although it can have a mortality rate of 15 percent in severe cases, up to 90% in pregnant women, and causes deafness in a quarter of survivors, there is no vaccine or antiviral to protect against Lassa virus.

19 Jul 2022

COVID-19 risks may be heightened by history of Lyme disease

Individuals with a history of Lyme disease, caused by tick bites are at a higher risk of severe COVID-19.

17 Jul 2022

Many individuals experience menstrual bleeding changes after SARS-CoV-2 vaccination

A new analysis of reports from more than 35,000 people offers the most comprehensive assessment so far of menstrual changes experienced by pre- and post-menopausal individuals in the first two weeks after receiving the COVID-19 vaccine.

15 Jul 2022

Texas Biomed professor to join $577 million effort for developing antivirals against COVID-19 and other viruses

As the coronavirus waves keep coming and cases are on the rise once again, the National Institutes of Health (NIH) recently launched a $577 million effort to develop antivirals against COVID-19 and other viruses with high pandemic potential.

15 Jul 2022

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.

15 Jul 2022

New mouse model faithfully mimics brain damage caused by severe Rift Valley Fever virus infection

A new mouse model identified by virologists from the University of Pittsburgh might revolutionize development of therapies targeting brain inflammation caused by Rift Valley Fever virus (RVFV).

15 Jul 2022

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

The COVID-19 pandemic pushed back years of progress made in combating antimicrobial resistance (AR) in the United States.

14 Jul 2022

Minimally invasive skin biopsy can help assess tissue damage related to SARS-CoV-2 infection

Using skin biopsy samples, investigators found that patients with severe COVID-19 had clots in small venous and arterial blood vessels in skin that appears normal.

14 Jul 2022

Epidemiologic features of the June 2022 monkeypox outbreak in Spain

Researchers described epidemiologic features of monkeypox cases reported in Spain and the intervention measures taken to control the outbreak.

14 Jul 2022

The disease burden and clinical severity of the SARS-CoV-2 Omicron BA.2 sublineage outbreak in Shanghai

Researchers estimated the severity and burden of COVID-19 in a recent outbreak in Shanghai, China.

14 Jul 2022

What are the biological features, prevention and control strategies against monkeypox?

Researchers elucidated the epidemiology and clinical presentation, biological features, pathogenicity and prevention and control strategies for monkeypox virus (MPXV) infections.

13 Jul 2022

Researchers gain unexpected insights into activation mechanism of flaviviruses

A collaboration between researchers at the Center for Virology of the Medical University of Vienna and the Pasteur Institute in Paris has provided unexpected insights into the atomic interactions of the tick-borne encephalitis (TBE) virus in infected cells.

13 Jul 2022

How do symptom burden and viral kinetics differ between healthy, vaccinated adults infected with either Delta, Omicron BA.1, or BA.2?

Researchers assessed the symptom profiles present in SARS-CoV-2 Delta, Omicron BA1. and BA.2-infected patients.

12 Jul 2022

Clinical presentation of monkeypox infection in two Israeli males

Researchers described the symptomatology and clinical manifestations of monkeypox infections among two Israeli patients.

12 Jul 2022

CDC posts investigation notice about multistate outbreak of Listeria infections

A CDC Investigation Notice regarding a multistate outbreak of Listeria infections has been posted: Listeria Outbreak | CDC.Listeria Outbreak | CDC

10 Jul 2022

Researchers analyze acute and post-acute COVID-19 presentations in athletes

Researchers at the University of São Paulo (USP) in Brazil analyzed data from 43 scientific articles describing the effects of COVID-19 on athletes and concluded that while the disease was asymptomatic or mild in the vast majority of cases (94%), about 8% of the subjects concerned had persistent symptoms affecting their performance and potentially preventing a return to training and competing.

8 Jul 2022

Vaccine and testing delays for monkeypox echo failures in early covid response

Andy Stone is one of the lucky ones. The New York City resident saw a tweet from a local AIDS activist saying that monkeypox vaccines would be available that day at a clinic in Manhattan

8 Jul 2022

What is the monkeypox transmission risk in metropolitan areas?

A new study discusses the possible patterns of spread of monkeypox, and strategies to contain such transmission.

7 Jul 2022

Q Fever News and Research

New $29 million grant awarded to five leading children’s hospitals for improving pandemic readiness

CDC experts update on monkeypox in the United States

Study shows how a critical Lassa virus protein drives infection

COVID-19 risks may be heightened by history of Lyme disease

Many individuals experience menstrual bleeding changes after SARS-CoV-2 vaccination

Texas Biomed professor to join $577 million effort for developing antivirals against COVID-19 and other viruses

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

New mouse model faithfully mimics brain damage caused by severe Rift Valley Fever virus infection

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

Minimally invasive skin biopsy can help assess tissue damage related to SARS-CoV-2 infection

Epidemiologic features of the June 2022 monkeypox outbreak in Spain

The disease burden and clinical severity of the SARS-CoV-2 Omicron BA.2 sublineage outbreak in Shanghai

What are the biological features, prevention and control strategies against monkeypox?

Researchers gain unexpected insights into activation mechanism of flaviviruses

How do symptom burden and viral kinetics differ between healthy, vaccinated adults infected with either Delta, Omicron BA.1, or BA.2?

Clinical presentation of monkeypox infection in two Israeli males

CDC posts investigation notice about multistate outbreak of Listeria infections

Researchers analyze acute and post-acute COVID-19 presentations in athletes

Vaccine and testing delays for monkeypox echo failures in early covid response

What is the monkeypox transmission risk in metropolitan areas?

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News